These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37990754)

  • 1. Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS-986231).
    Pellicori P; Cleland JGF; Borentain M; Taubel J; Graham FJ; Khan J; Bruzzese D; Kessler P; McMurray JJV; Voors AA; O'Connor CM; Teerlink JR; Felker GM
    Eur J Heart Fail; 2024 Jan; 26(1):142-151. PubMed ID: 37990754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.
    Lang NN; Ahmad FA; Cleland JG; O'Connor CM; Teerlink JR; Voors AA; Taubel J; Hodes AR; Anwar M; Karra R; Sakata Y; Ishihara S; Senior R; Khemka A; Prasad NG; DeSouza MM; Seiffert D; Ye JY; Kessler PD; Borentain M; Solomon SD; Felker GM; McMurray JJV
    Eur J Heart Fail; 2021 Jul; 23(7):1147-1155. PubMed ID: 33620131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.
    Felker GM; McMurray JJV; Cleland JG; O'Connor CM; Teerlink JR; Voors AA; Belohlavek J; Böhm M; Borentain M; Bueno H; Cole RT; DeSouza MM; Ezekowitz JA; Filippatos G; Lang NN; Kessler PD; Martinez FA; Mebazaa A; Metra M; Mosterd A; Pang PS; Ponikowski P; Sato N; Seiffert D; Ye J
    JACC Heart Fail; 2021 Feb; 9(2):146-157. PubMed ID: 33248986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
    Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
    ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
    Galluzzo A; Frea S; Boretto P; Pidello S; Volpe A; Canavosio FG; Golzio PG; Bergerone S; De Ferrari GM
    Clin Res Cardiol; 2020 Oct; 109(10):1251-1259. PubMed ID: 32144493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
    Tomiyama H; Nakayama T; Watanabe G; Shiojima K; Sakuma Y; Yamamoto A; Imai Y; Yoshida H; Doba N
    Am Heart J; 1999 Mar; 137(3):543-8. PubMed ID: 10047639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
    Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
    JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
    Udelson JE; Bilsker M; Hauptman PJ; Sequeira R; Thomas I; O'Brien T; Zimmer C; Orlandi C; Konstam MA
    J Card Fail; 2011 Dec; 17(12):973-81. PubMed ID: 22123358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF).
    Schulze PC; Bogoviku J; Westphal J; Aftanski P; Haertel F; Grund S; von Haehling S; Schumacher U; Möbius-Winkler S; Busch M
    Circulation; 2022 Jul; 146(4):289-298. PubMed ID: 35766022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
    Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
    Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.